Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
about
Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancerAnti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalCardiac Extracellular Vesicles in Normal and Infarcted HeartThe Regulatory Role of MicroRNAs in EMT and CancerProstate cancer invasion and metastasis: insights from mining genomic data.Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?TGF-β1 induces HMGA1 expression: The role of HMGA1 in thyroid cancer proliferation and invasion.Requirement of podocalyxin in TGF-beta induced epithelial mesenchymal transition.Molecular imaging of breast tumors using a near-infrared fluorescently labeled clusterin binding peptide.Characterisation of the vitreous proteome in proliferative diabetic retinopathy.Expression of metabolic, tissue remodeling, oxidative stress, and inflammatory pathways in mammary tissue during involution in lactating dairy cowsMolecular pathways and targets in prostate cancerProteomic analysis on N, N'-dinitrosopiperazine-mediated metastasis of nasopharyngeal carcinoma 6-10B cells.Dynamic actin remodeling during epithelial-mesenchymal transition depends on increased moesin expression.Expression of E-selectin ligands on circulating tumor cells: cross-regulation with cancer stem cell regulatory pathways?Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion.Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway.GDF10 is a signal for axonal sprouting and functional recovery after stroke.Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1.Identification of the thiol isomerase-binding peptide, mastoparan, as a novel inhibitor of shear-induced transforming growth factor β1 (TGF-β1) activation.The effects of wenxin keli on p-wave dispersion and maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation: a meta-analysis of randomized controlled trials.Chemopreventive effect of Korean Angelica root extract on TRAMP carcinogenesis and integrative "omic" profiling of affected neuroendocrine carcinomas.Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancerClusterin signals via ApoER2/VLDLR and induces meiosis of male germ cells.Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update.Potential nanotechnologies and molecular targets in the quest for efficient chemotherapy in ovarian cancer.Targeting heat shock proteins in metastatic castration-resistant prostate cancer.miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancerHeat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential.Gastrin upregulates the prosurvival factor secretory clusterin in adenocarcinoma cells and in oxyntic mucosa of hypergastrinemic rats.Clusterin induces matrix metalloproteinase-9 expression via ERK1/2 and PI3K/Akt/NF-κB pathways in monocytes/macrophages.The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival.Exosomes: A Rising Star in Falling Hearts.microRNAs and Prostate Cancer.
P2860
Q24632276-7C5ED111-237B-442A-BCB0-EB0393925C2CQ26744536-551613D5-24B6-4D86-8EFC-80401DD56A33Q26770294-4157BF91-FDF0-481A-8094-6FAD78B5E40AQ28391426-75A008B6-DAA8-4069-9102-C33625174267Q30656758-77605C48-1995-4B01-A447-0706ADF2707DQ33351622-35515E44-2818-467F-AE74-D5DEA010AAF7Q33598619-9CA40262-7B30-4BC7-AEA3-9E39ADE749E2Q33886903-83521186-E4B4-4C91-9F3C-1C6D1AD3C4F7Q34084282-C9B85548-E5A3-4150-B862-1E83D4873E95Q34184946-DB5AB2B6-5851-4262-AEDB-B6F2E47EC85CQ34240490-ABB50218-5826-4D41-818E-9D47F8D20FA5Q34365632-E4B9AE6C-FEED-4BAC-A3BE-1B6BBA21164BQ34479612-CEA83AEF-A32B-4497-8EBE-6CA0E472892BQ35612241-CAB470F1-3930-4818-8904-304A9C599F3BQ36175119-D2A7E7BF-3622-406F-AFF6-09CD83391DEDQ36223133-2BC92992-4533-417B-8CC0-D15548A185D7Q36562209-BA2FD09C-5A6B-4EA1-ADFF-781EFC9ECC34Q36682829-BE8A88EF-0479-4F60-BB8D-51548174D7CFQ36746688-BB4AD75E-BCD6-4DBE-8C86-44414DB21F78Q36760362-3E8448D8-18BE-4A5F-8F6D-87EDB922F2D0Q36801789-5A82FD4C-C6B3-4643-BA9E-BE2A16E3B969Q36915415-DB21CD30-EF06-4909-AEA8-18903711384DQ37683681-915E971C-171C-4802-A2A1-0C402604E275Q37733021-34208710-5ACF-4E30-8AE7-CCDA262CDFD7Q37918451-253E5F73-AE47-4948-847B-F1D3898D87D6Q38258602-8FB7EE59-F8A2-4DD5-98D9-977CD223EAB3Q38289945-31C7F231-F162-4A57-981B-AC9B9140631AQ38447274-681D66FB-AC0B-4182-A12B-FEF06159725EQ38725577-AE5A567D-A27E-4688-96D4-744680568DADQ39458732-E4936AE9-8FC0-43FB-A97F-1ED68161819AQ39509541-0133D3DA-59A7-4063-AC54-6ABE62356321Q40048875-BE2FCAE9-7F4F-4BBE-87D4-7F5B76224AFCQ41001027-C24655CB-341B-4051-A4C7-EBEBDA2D11F2Q53767542-265DE3D5-4174-4FFA-9FC3-B56285F4E70B
P2860
Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Transcriptome profiling of a T ...... et for therapeutic antibodies.
@en
Transcriptome profiling of a T ...... et for therapeutic antibodies.
@nl
type
label
Transcriptome profiling of a T ...... et for therapeutic antibodies.
@en
Transcriptome profiling of a T ...... et for therapeutic antibodies.
@nl
prefLabel
Transcriptome profiling of a T ...... et for therapeutic antibodies.
@en
Transcriptome profiling of a T ...... et for therapeutic antibodies.
@nl
P2093
P2860
P356
P1433
P1476
Transcriptome profiling of a T ...... get for therapeutic antibodies
@en
P2093
A E G Lenferink
B Paul-Roc
M Banville
M D O'Connor-McCourt
Y Durocher
P2860
P2888
P304
P356
10.1038/ONC.2009.399
P407
P577
2009-11-23T00:00:00Z